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Abstract
The manuscript will discuss the epidemiology and etiology of the adult with coarctation 
of the aorta (CoA) as well as describe the embryology, anatomy, pathophysiology, and 
clinical presentation in order to recognize and appropriately diagnose an adult patient 
with CoA. This chapter will also review diagnostic testing, management, therapeutic 
interventions including percutaneous and surgical procedures, and long-term complica-
tions that can arise in an adult with repaired CoA. It contains images with examples from 
echocardiography, cardiac computed tomography (CT), magnetic resonance imaging 
(MRI), and angiograms as part of the description.
Keywords: congenital heart disease, coarctation of the aorta, percutaneous intervention, 
balloon dilatation, stenting, surgery, management, complications
1. Introduction
Coarctation of the aorta is a congenital cardiac defect. It usually manifests as a discrete con-
striction of the aortic isthmus. However, it is more likely to represent a spectrum of aortic nar-
rowing from this discrete entity to tubular hypoplasia, with many variations seen in between 
these two extremes. Morphologists argue that tubular hypoplasia, although it may coexist 
with discrete coarctation, should be considered as a separate entity [1]. On rare occasions 
there can be a gap between the ascending and descending thoracic aorta, known as an inter-
rupted aortic arch. Interventions can be required as an infant however procedures may be 
needed later in life for native coarctation or patients with recurrent coarctation. The presence 
of associated arch hypoplasia is relevant to longer term risk for the development of hyperten-
sion so in addition to re-coarctation, these patients are at increased risk for developing other 
comorbidities and should have lifelong follow up care.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Epidemiology
Coarctation of the aorta (CoA) is the fifth most common congenital heart defect, accounting 
for 6–8% of live births with congenital heart disease, with an estimated incidence of 1 in 2500 
births [2–5]. It affects more male babies than female, with a reported ratio in males of between 
1.27:1 and 1.74:1 [6, 7]. Patients with CoA can have other defects like atrial septal defect (ASD), 
ventricular septal defect (VSD), atrioventricular canal defect (AVCD), bicuspid aortic valve 
(BAV), transposition of great arteries (TGA), patent ductus arteriosus (PDA), hypoplastic left 
heart syndrome. CoA often coexists with other left heart obstructive lesions like mitral steno-
sis, subaortic stenosis and aortic stenosis. About 50–60% patients with coarctation of the aorta 
or interrupted aortic arch have a BAV [8]. Compared to right-sided lesions, left-sided cardiac 
obstructions are more frequently seen in males than female [2]. One genetic condition noted 
to be associated with an increased risk of having coarctation of the aorta (12–35%) is Turner 
syndrome [9]. Lastly, the etiology of CoA is not well understood and thought to be affected 
by various factors including a genetic component, environmental factors, and arteriopathy.
3. Etiology and cardiac associations
The etiology of the discrete isthmic constriction of the aorta seen in patients with CoA 
remains controversial and is thought to be multifactorial. Although the precise pathogenesis 
is unknown, the two theories for the development of congenital coarctation of the aorta have 
been postulated: reduced antegrade intrauterine blood flow causing underdevelopment of 
the fetal aortic arch [10] and migration or extension of ductal tissue into the wall of the fetal 
thoracic aorta [11]. Histologic examination of localized aortic coarctation lesions has demon-
strated the presence of a tissue ridge extending from the posterior aortic wall and protruding 
into aortic lumen. This ridge consists of ductal tissue with in-folding of the aortic media [12]. 
Prenatal environmental exposures have been associated with CoA and other left-sided lesions. 
However, there is a growing body of literature that suggests a genetic basis for development 
of these lesions [13]. There has been evidence of genetic contribution to CoA [14, 15]. Vascular 
endothelial growth factor (VEGF) plays a vital role in aortic development, acting as a chemo-
attractant, stimulating angioblast migration toward the midline before formation of the aorta. 
Indeed, targeted disruption of VEGF in mice leads to significant disruption of the developing 
aorta [16]. Whether an initial mutation leads to secondary effects on VEGF or on other signal-
ing systems involved in recruiting mural cells in fetuses, leading to CoA, is unknown. An 
increase in collagen and decrease in smooth muscle content of the pre-coarctation aorta in 
humans has been demonstrated in comparison to post-coarctation aorta or to proximal aorta 
of young transplant donors [17]. Recently, mutations in the NOTCH1 gene have been iden-
tified in individuals with left ventricular outflow tract malformation, including coarctation 
[18]. Up to 18–30% of patients with Turner syndrome have coarctation [19]. Genetic testing for 
Turner syndrome (i.e., karyotype analysis) should therefore be performed in female patients 
diagnosed with coarctation of the aorta [20, 21]. Mechanical models have suggested that 
abnormalities of blood flow, defective endothelial cell migration, and excessive deposition 
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of aortic duct tissue at the aortic isthmus can result in coarctation [22]. Epidemiological 
studies have found that for left ventricular outflow tract lesions, there is a higher chance of 
concordant diagnosis in multiple family members [23]. The co-existence of CoA with other 
left heart obstructive pathologies like aortic stenosis and hypoplastic left heart syndrome 
suggests that there could be a common pathogenic mechanism at a molecular level [24, 25]. 
Williams syndrome, a congenital and multisystem genetic disorder, has been associated with 
supravalvular aortic stenosis. Aortic arch abnormalities, including coarctation, are present in 
10% of patients with Williams syndrome [26]. Coarctation can also be present in congenital 
cardiovascular anomalies involving multiple left-sided lesions, including Shone syndrome 
and hypoplastic left heart syndrome [22]. Environmental factors could also play a role in the 
incidence of CoA since there is increase CoA rate along the US-Mexico border [27]. Seasonal 
variations have been reported in the incidence of CoA we well [28].
4. Noncardiac associations
The link between intracranial aneurysms and CoA was described well before the surgical era, 
accounting for 5% deaths in patients with aortic coarctation on autopsy review [29]. Most of 
the aneurysms described are small, and therefore have a low risk of spontaneous rupture. 
Currently the benefits of routine screening for intracranial aneurysms in coarctation remain 
unclear [22].
5. Anatomy
Although most patients have a discrete narrowing of the descending aorta at the insertion 
of the ductus arteriosus, there is a spectrum of aortic narrowing that encompasses the usual 
discrete thoracic lesions, long-segmental defects, tubular hypoplasia, and, rarely, coarctation 
located in the abdominal aorta. In simple terms, coarctation is characterized by discrete nar-
rowing of the thoracic aorta adjacent to the ligamentum arteriosum. Importantly, discrete 
coarctation is an aortopathy that lies within a spectrum of arch abnormalities ranging from 
discrete narrowing to a long segment of arch hypoplasia. Morphologically it appears as a 
localized shelf in the posterolateral aortic wall. There are some anatomic variations of coarcta-
tion. It maybe appear as (a) discrete narrowing (b) tubular hypoplasia of any part of the arch 
or (c) aortic arch interruption [30]. CoA has also been described as a diffuse arteriopathy 
with abnormalities in the elastic properties of the aorta. Increase in collagen and decreases in 
smooth muscle component of the pre-coarctation aorta have been reported [31].
Although CoA can be an isolated CHD, it is also commonly found in other congenital syn-
dromes and cardiovascular anomalies. Thus, deliberate investigation for the presence of 
coarctation should be made in these patients. The most common cardiovascular malformation 
associated with CoA is BAV. Prior autopsy examination showed 46% of patients with CoA 
have congenital BAV [32]. The relative frequency of associated cardiac lesions in patients with 
CoA differs somewhat based upon the age of the population studies. Adult patients with CoA 
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evaluated with magnetic resonance imaging, 17% had no additional cardiovascular anomalies 
however, in this cohort, BAV, arch hypoplasia, VSD, and PDA were detected in 60, 14, 13, and 
7% of patients, respectively [33]. The coincidence of BAV and CoA is difficult to determine, 
because BAV is very common and not everyone is screened for the presence of coarctation.
6. Pathophysiology and presentation
The clinical presentation of coarctation differs significantly in pediatric patients in com-
parison with adults. Although infants with severe coarctation may present with signs and 
symptoms of heart failure and cardiogenic shock as the ductus closes, most adults with 
unrepaired coarctation are generally asymptomatic. A common presentation of coarctation is 
systemic arterial hypertension. The causes of hypertension in this cohort of patients are not 
fully understood, but malfunction in a number of individual systems have been implicated, 
including imbalance within the autonomic nervous system [34], impaired vascular function 
[35, 36] and hyperactivation of the rennin–angiotensin system [37, 38]. It is likely that more 
than one of these systems is involved. In young adults presenting with severe upper extrem-
ity hypertension, coarctation should be excluded. Patients presenting with severe hyperten-
sion may experience symptoms including angina, headache, epistaxis, and heart failure [22]. 
Coarctation causes upper extremity hypertension, which leads to systemic hypertension and 
left ventricular hypertrophy. There have been several mechanisms proposed for hypertension 
in patients with coarctation, which include reduced arterial compliance, blunted barorecep-
tor sensitivity and endothelial dysfunction [39]. Age at repair is an important determinant 
of developing late hypertension. Patients who get the repair in infancy have less than 5% 
chance of developing hypertension by early adulthood, whereas those operated on after the 
age of one have a 25–33% chance of developing hypertension [40–42]. Late hypertension is 
associated with residual or recurrent obstruction. Despite the variability in blood pressure in 
the upper and lower extremities, regional blood flow is generally maintained within normal 
limits by autoregulatory vasoconstriction in the hypertensive areas and by vasodilation in the 
hypotensive areas [43]. Nonetheless some patients with satisfactory repair can still develop 
late hypertension due to vascular dysfunction [44]. In a systemic review of literature, the 
median prevalence of late hypertension after satisfactory repair was reported to be 32% with 
a range of 25–68% [45]. Ambulatory blood pressure monitoring can help in early diagnosis of 
late hypertension [46]. Patients with coarctation remain at a high risk of developing complica-
tions like premature coronary atherosclerosis, cerebrovascular events, left ventricular systolic 
dysfunction and endocarditis. With early repair, timely recognition of late hypertension and 
treatment of risk factors, the overall survival has improved. However, the life expectancy of 
these individuals is not as normal as the unaffected peers [47].
In full term newborns one of the important causes of congestive heart failure is aortic coarcta-
tion. Beyond the neonatal period most patients are asymptomatic and present with difficult to 
control hypertension in later years. In previously undiagnosed adults, the classic presenting 
sign is hypertension. Older patients might complain of headaches, leg fatigue with exercise 
and cold extremities. As mentioned previously, coarctation can be a part of syndromes like 
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Turner syndrome, Williams Syndrome or Shone’s complex. Almost 50% of the cases are asso-
ciated with BAV. Other associated abnormalities include intracranial aneurysms (most com-
monly of the circle of Willis) in 2–10% case and acquired intercostal artery aneurysms [30]. 
Data on the natural history of coarctation of the aorta are largely derived from hospital post-
mortem records and from case series prior to the availability of operative repair that was first 
done in 1945 [48]. The average survival age of individuals with unoperated coarctation was 
approximately 35 years of age, with 75% mortality by 46 years of age [49]. Common complica-
tions in unoperated patients or in those operated on during later childhood or adulthood 
were systemic hypertension, accelerated coronary artery disease, stroke, aortic dissection, 
and heart failure. Causes of death include heart failure, aortic rupture, aortic dissection, endo-
carditis, endarteritis, intra-cerebral hemorrhage, and myocardial infarction [48, 50]. Patients 
with an associated BAV may also develop significant aortic stenosis, aortic regurgitation, and 
dilated ascending aorta from myxomatous degeneration of the medial wall of the aorta.
6.1. Pregnancy and coarctation
Coarctation of the aorta and associated lesions, particularly BAV, aortic stenosis, and ascending 
aorta dilation should be evaluated before pregnancy for appropriate counseling and advice. 
Rarely the first manifestation is during pregnancy. In the absence of hemodynamically signifi-
cant stenotic lesion, pregnancy is well tolerated in patients with repaired aortic coarctation. 
However there is a greater propensity of developing hypertension during pregnancy [51]. 
Outcome of pregnancy in patients after repair of aortic coarctation have been reported over the 
last decade [52]. During pregnancy and delivery, there were no serious cardiovascular com-
plications. Hypertension alone was reported in 21 pregnancies in 14 women, and preeclamp-
sia in 5 pregnancies in 4 women. In another study, serious complications were uncommon 
in women with a hemodynamically significant gradient (≥20 mmHg) after repair [53]. 
These women were more likely to have systemic hypertension related to the increased coarc-
tation gradient. However, there are case reports of aortic rupture or dissection that occur with 
pregnancy after coarctation repair due to the hemodynamic and aortic medial changes of 
pregnancy, which remain rare.
7. Physical exam
On physical examination, femoral arterial pulses are diminished and usually delayed. Rarely, 
claudication may be reported because of lower extremity ischemia. Auscultation of the left 
sternal border may demonstrate a harsh systolic murmur with radiation to the back. An asso-
ciated thrill may be palpable in the suprasternal notch. If left ventricular pressure or volume 
overload have developed, a left ventricular lift can be present. The finding of a continuous 
murmur may suggest the presence of arterial collaterals in those with long-standing unre-
paired significant coarctation [22].
If aortic coarctation is suspected blood pressure should be measured in both arms and legs 
in supine position. Normally BP in the lower extremities is 10–20% higher than the upper 
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extremities due to wave amplification. If BP in the leg is lower than the arm BP by 10 mmHg 
or more then coarctation should be suspected. A pressure gradient of 35 mmHg or greater is 
considered highly specific for coarctation [54]. The presence of collateral vessels may dimin-
ish the pressure gradient. Arterial pulsations from collaterals to the intercostal and inter-
scapular arteries can also be palpated. In patients with suspected coarctation, it is important 
to assess for systolic blood pressure discrepancy between upper and lower extremities. The 
upper extremity systolic blood pressure is usually 20 mmHg higher than the lower extremi-
ties in patients with significant coarctation. In rare instances of coarctation patients with con-
comitant anomalous subclavian artery origin distal to the coarctation, systolic blood pressure 
differences may not be detected between ipsilateral arm and legs. On auscultation a continu-
ous murmur of aortoaortic collateral arteries would be audible in the interscapular space. 




The electrocardiogram of a patient with coarctation may be normal or demonstrate evidence 
of left ventricular hypertrophy from chronic left ventricular pressure overload. On chest 
radiograph, a “figure of three” sign formed by the aortic nob, the stenotic segment, and the 
dilated post stenotic segment of the aorta suggests CoA. The heart border can be normal or 
mildly enlarged. Inferior rib notching can also be seen in the third to eighth ribs bilaterally 
caused by the presence of dilated intercostal collateral arteries [22, 30].
8.2. Echocardiography
Transthoracic echocardiography is the most accessible and the main stay for the practicing 
physician. A comprehensive echocardiogram is recommended in the initial evaluation of a 
patient with repaired or suspected CoA. In addition to characterization of the coarctation 
itself, it is important to evaluate for evidence of left ventricular pressure or volume over-
load, left ventricular hypertrophy, size, and left ventricular systolic and diastolic dysfunction. 
Particular attention should be placed in identifying associated cardiac defects especially left-
sided lesions. The morphology of the aortic valve, and evidence of subvalvular, valvular, and 
supravalvular aortic stenosis should be interrogated. The dimensions of the aortic root and 
ascending aorta can be followed serially to assess for associated aortopathy. Suprasternal 
windows are important to view the aortic arch from the long-axis view, in two-dimensional 
imaging and by color flow Doppler. Visualization of the aortic arch in the long axis may 
demonstrate a focal area of narrowing of the thoracic aorta distal to the takeoff of the left 
subclavian artery with associated flow turbulence on color flow Doppler.
Coarctation is imaged from the high left parasternal views with lateral angulation of the 
probe toward the left shoulder. The suprasternal notch view is used for obtaining Doppler 
gradient (Figures 1 and 2). Subcostal imaging is used to evaluate the distal thoracic and upper 
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abdominal aorta. The stenotic segment may be discrete, segmental or long therefore the entire 
aortic arch should be imaged particularly the origin of the left subclavian artery as in trans-
verse arch hypoplasia the distance between the origin of the left common carotid artery and 
left subclavian artery may be increased. Low frequency imaging and harmonic imaging can 
improve the image quality.
On doppler imaging color flow aliasing would be seen at and beyond the narrow segment. 
Systolic velocity in the descending aorta is increased. If transverse arch hypoplasia is pres-
ent the proximal velocity increases as well therefore the systolic pressure gradient should be 
calculated with the expanded Bernoulli equation 4 (V22-V12) [55, 56]. In severe cases there is 
a gradient during both systole and diastole across the stenosis, which results in the classic 
saw tooth pattern. The presence of collateral arteries can cause doppler to underestimate the 
severity of obstruction [57]. Some of the other factors, which can affect the Doppler gradient, 
include severe obstruction, long tortuous vessels or eccentric gradient. Yet with long-standing 
coarctation, significant collaterals may have developed thereby reducing the peak systolic 
gradient across the site of stenosis. A saw-tooth pattern seen on continuous-wave Doppler 
reflects the persistent forward flow in diastole because of diastolic run-off. Higher gradient 
across the coarctation and longer duration of diastolic forward flow in the thoracic aorta sug-
gest more significant coarctation [22].
In the absence of proximal obstruction when the pulse wave doppler is placed in the abdomi-
nal aorta, the wave form shows a rapid systolic upstroke, short deceleration time, followed 
by a brief early diastolic flow reversal and little anterograde flow throughout diastole. In the 
presence of coarctation there is loss of early diastolic flow reversal, which is highly sensitive 
Figure 1. 2D transthoracic echo imaging showing coarctation of the aorta distal to the left subclavian artery.
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for detection of upstream obstruction. The systolic velocity is blunted, there is continuous 
anterograde flow and increased diastolic flow velocity. If the delay between R wave on ECG 
and peak velocity of the abdominal aorta is >50 ms it is associated with coarctation [58].
8.3. Magnetic resonance imaging
Magnetic resonance imaging (MRI) is the most comprehensive method of evaluating coarcta-
tion of the aorta. MRI does not expose the patients to ionizing radiations, which is an important 
consideration for young patients who would have to undergo serial imaging. Cardiac MRI 
(cMRI) has become a valuable noninvasive modality to assess patients with unrepaired and 
repaired coarctation. In adults with suboptimal echocardiographic imaging window, cMRI 
can be used to characterize the aortic valve, aortic root, left ventricular size, and function. 
cMRI, along with gadolinium-enhanced magnetic resonance angiography, provides excellent 
resolution of cardiac anatomy and vascular structures. Compared with echocardiography, 
cMRI demonstrates superior visualization of the aortic arch with precise characterization 
of the location and extent of coarctation, and assessment of the presence and extent of col-
lateral vessels. n the unrepaired patient, the measured minimum aortic cross-sectional area 
and heart rate–corrected deceleration time in the descending aorta can be used to predict a 
significant gradient by cardiac catheterization [59] and future need for interventions. cMRI 
provides exceptional visualization of the aortic arch and detection of post repair complica-
tions including arch “kinking” and pseudoaneurysms. Thoracic aortic magnetic resonance 
angiography also provides assessment of post stenotic dilation or aneurysmal formation at 
the site of a previous repair. Importantly, the lack of ionizing radiation provides an advantage 
of cMRI over CT, in the serial evaluation of late complications after repair [22, 59].
Figure 2. Pulse wave doppler profile through the coarctation segment demonstrating a pressure gradient.
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A stack of half-Fourier acquisition single shot turbo spin-echo (HASTE) images of the medias-
tinum are acquired in transverse, coronal and oblique sagittal plane parallel to the plane of the 
aortic arch. These provide dark blood images, which give anatomical overview of the coarcta-
tion. Black blood images are less susceptible to artifact from metallic objects. For evaluation 
of left ventricular function and mass a stack of steady state free precession (SSFP) cine images 
is acquired in the left ventricular short axis plane. Long axis cine images are acquired in the 
four, two and three chamber planes. SSFP cine images are then performed through the aortic 
root in the plane of the aortic valve, the aortic arch and the region of the aortic isthmus. Phase 
contrast flow imaging is performed to quantify the flow volumes and velocity [60].
Figure 3. (A) 2D echo with color flow doppler showing severe narrowing of the proximal descending aorta with 
significant turbulence and a peak velocity of 4.8 m/s consistent with severe aortic coarctation. (B) Doppler tracing shows 
delay in return to baseline in diastole (diastolic drag) and blunting of the abdominal aortic doppler pattern consistent 
with significant aortic coarctation.
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Figure 4. 3D reconstruction (CT angiogram) showing discrete segment of CoA and mild dilatation of the descending 
thoracic aorta distal to coarctation segment.
With phase contrast imaging the degree of collateral flow can be determined. The flow volume 
is assessed in the aorta just proximal to the stenosis and then at the level of the diaphragm. 
Usually there is a 7% decrease in total flow from proximal to distal aorta, if there is increase in 
flow by 5% or more, it is highly indicative of collateral flow joining the descending aorta [61]. 
Four-dimensional flow MR imaging is an emerging tool to evaluate hemodynamic signifi-
cance of collateral blood flow (Figure 3) [62].
8.4. Computed tomographic angiography (CTA)
Although cMRI is the preferred mode of serial follow-up for patients after coarctation repair, 
the use of cardiovascular CT may be considered in selected patients. In particular, cMRI in 
patients with transcatheter stents may have susceptibility artifact precluding accurate assess-
ment of late complications associated with these interventions. With cMRI, metallic artifact 
can lead to difficulty in the assessment of vessel lumen patency, identifying restenosis, aneu-
rysm, or stent fracture [22]. Use of CT obviates concerns about metallic artifact impairing 
accurate assessment of stented segments of the aorta. Other advantages of cardiac CT over 
cMRI include improved image resolution, shorter scan time, and greater availability [22]. CTA 
is also used to assess concomitant coronary anomalies that may not be well visualized with 
cMRI. Patients with pacemakers or implantable cardioverter defibrillators that are not cMRI 
compatible may benefit from surveillance with cardiovascular CTA. Similar to cMRI, cardio-
vascular CT can be performed to image the coarctation segment, any aneurysmal dilation 
distal to the coarctation segment, recoarctation post repair, (Figures 4–7), hypoplasia of the 
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aortic arch, follow serial aortic dimensions and can also show associated vascular anomalies 
such as double superior vena cava or aberrant great vessels. Collateral vessel formation can 
also be visualized with CTA. The main disadvantage of CTA is radiation exposure, there-
fore dose-saving algorithms are very important in reducing radiation exposure for patients 
(Figures 8–11).
Figure 5. CT angiogram sagittal view of discrete coarctation segment distal to the left subclavian artery.
Figure 6. CT angiogram showing recurrent CoA.
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Figure 8. Cardiac MRI of interrupted aortic arch Type A status post a vascular jump graft resulting in a C-shaped 
appearance of the distal arch and multiple areas of stenosis now with a 20 mm extra-anatomic bypass graft from the mid 
ascending aorta to the distal descending aorta at the level of the diaphragm. The last picture in this figure shows a three 
dimensional (3D) reconstructed image of the graft.
Figure 9. Invasive angiogram showing Type A interruption of the aorta.
Figure 7. CT 3D reconstruction of the aorta postsurgical repair of CoA.
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9. Management
In 2008, the American College of Cardiology and American Heart Association (ACC/AHA) 
guidelines for adults with congenital heart disease recommended intervention for coarctation 
for the following indications:
a. Peak to peak coarctation gradient ≥20 mmHg. The peak to peak gradient is a measure-
ment derived from catheterization data in which the peak pressure beyond the coarctation 
is subtracted from the peak pressure proximal to the coarctation.
b. Peak to peak coarctation gradient <20 mmHg with anatomic imaging evidence of signifi-
cant coarctation and radiologic evidence of significant collateral flow [49, 50].
Figure 10. Angiography demonstrating stent placement in a patient with coarctation of the aorta.
Figure 11. CT angiogram showing Type A interruption of the aortic arch.
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Systemic hypertension, accelerated coronary heart disease, stroke, aortic dissection, and heart 
failure are common complications in adults who have not undergone correction for their 
coarctation or were operated on later in life [49]. Coarctation repair after early childhood does 
not prevent persistence or late recurrence of systemic hypertension. As a result, correction of 
coarctation should be performed in infancy or early childhood to prevent the development 
of chronic systemic hypertension [42]. If coarctation escapes early detection, repair should 
be performed at the time of subsequent diagnosis if clinically indicated. Management with 
antihypertensive medications is important to prevent long-term complications [2]. According 
to guidelines, the first line medications in the treatment of hypertension in patients with CoA 
are angiotensin converting enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARB), 
and beta blockers (BB) [50]. Hypertension can be treated with medical management, but 
coarctation or recoarctation of the aorta need to be repaired either percutaneously or surgi-
cally [47, 63]. Choosing one intervention over another depends on the individual patient and 
should be done in collaboration with an interdisciplinary team including an adult congenital 
heart disease (ACHD) cardiologist, interventionalist and surgeon with training in ACHD. For 
example, patients with a long segment of coarctation of the aorta, complex arch anatomy, 
or with interruption of the aorta are more likely to need open-heart surgery as opposed to a 
transcatheter intervention [64, 65].
9.1. Percutaneous intervention
In the mid-1900s, repair of coarctation of the aorta was entirely surgical. Balloon angioplasty 
is a percutaneous alternative to surgical repair for older infants and young children (greater 
than 4 months) with native discrete coarctation. It remains the preferred intervention for all 
patients with isolated recoarctation regardless of age [49, 66]. However, stent placement has 
replaced balloon angioplasty as the procedure of choice in older children and adults with 
native coarctation [66]. Currently, balloon dilatation and stenting remain the transcatheter 
interventions that can be used for the treatment of CoA [63, 67]. Although balloon angioplasty 
was the treatment of choice for discrete native coarctation in adults in the past, most centers 
currently perform stent implantation for older children and adults with native discrete or 
long-segment coarctation. Through-out the years, continuous advancements in technology 
and catheter-based techniques have made a variety of percutaneous intervention possibili-
ties available. Improvements in the field have allowed interventions to evolve from balloon 
angioplasty to endovascular stents to covered stents. The patients who underwent balloon 
angioplasty were noted to develop residual or recurrent stenosis, aneurysms and dissections 
or femoral artery complications including occlusion [68]. Stenting, on the other hand, have 
been shown to be superior to balloon dilatation in relieving the aortic coarctation, with less 
recurrent narrowing of the aorta, as well as having a smaller amount of complications. Studies 
have shown that balloon angioplasty and surgical correction are equally effective in reducing 
the peak systolic pressure gradient early after intervention [69]. The development of covered 
stents has helped decrease the number of problems associated with injury to the aortic wall 
and have allowed providers to avoid surgical interventions for aneurysms [2]. Overall, the 
repair of complex coarctation of the aorta with stents has been shown to be safe with improve-
ments in outcomes [70]. Bare metal stents may be sufficient in many, if not most, patients that 
undergo stent placement and that further research is needed to determine if there is a subset 
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of patients who truly benefit from the implantation of a covered versus bare stent. Follow-up 
data will also be important to see if there is a long-term benefit regarding maintaining normal 
blood pressure using covered stents. Stenting may be less successful in patients with subop-
timal anatomy with vessel tortuosity and transverse arch hypoplasia [71]. For these patients, 
the decision to perform stent placement versus surgical correction must be made on a case-
by-case decision by the clinical team.
9.2. Surgical
Resection and direct end-to-end anastomosis or subclavian flap arterioplasty are the most com-
monly used techniques for the treatment of CoA in the infantile period because anatomic con-
ditions are more favorable. Subclavian flap arterioplasty and patch graft aortoplasty have been 
developed as an alternative to resection and direct end-to-end anastomosis in which more than 
one-half of patients experience late-onset re-coarctation problems [72]. However, CoA in ado-
lescents and adults is often complicated with the occurrence of associated comorbidities like 
aortic aneurysms, dissections, aortic valve disease, and other cardiovascular diseases. Studies 
actually show that having a BAV is a risk factor for mortality [73]. This is most likely because 
BAV have been associated with aortic insufficiency and stenosis in addition to dilatation and 
dissection of the aorta resulting in a potential need for open heart surgery. In a retrospective 
study of patients with CoA undergoing surgical interventions, aortic aneurysm or dissection 
and disease of the aortic valve were the most common comorbidities. Within this cohort, 38% 
had a BAV [72]. Patients with CoA who have left ventricular dysfunction and a brachial-ankle 
gradient of 20 mmHg or greater have also shown to be at risk for significant cardiovascular 
events [47]. Earlier, CoA was evaluated as the localization anomaly of the aorta; however, it is 
currently considered as part of a broad-spectrum pathology. The main goal of surgical treat-
ment in CoA is the removal of stenosis. The surgical technique is selected according to the 
length of the coarcted segment, localization with the ductus, status of the collateral circulation 
in the distal aorta, and atherosclerotic alterations in the aortic wall [72]. The resection and 
graft interposition were first described by Gross in 1951 [74, 75]. This technique is not suit-
able for pediatric patients, because it restricts the development of the aorta. However, bypass 
grafting is an appropriate technique particularly for patients with aneurysms, long-segment 
coarctation or post-recovery aneurysms, and adult patients with diffuse collateral circulation 
and coarctations. Therefore, artificial bypass grafting was preferred in these patients to prevent 
complications (i.e., spinal cord complications, bleeding, and aneurysm development) during 
and after surgery [76]. Prosthetic patch aortoplasty is avoided whenever possible because of 
the frequent occurrence of aortic aneurysm or rupture [77]. When surgical repair of the coarcta-
tion is done at a later age, the possibility of these cardiovascular comorbidities should be kept 
in mind. Some of the other risks in surgery to consider are related to spinal ischemic injuries 
and intraoperative bleeding from extensive amounts of collaterals [2]. In general, repair of the 
CoA surgically has been shown to have a low mortality rate. However, as these patients con-
tinue to follow up with their cardiologists, re-coarctation is often seen in the long-term. Other 
than additional percutaneous procedures, these patients sometimes need to be evaluated for 
further surgical interventions [78]. Currently, there are no clinical trials showing a direct com-
parison between transcatheter approaches are superior to surgical interventions or vice versa. 
More research is needed in this area to compare the different approaches [64].
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10. Complications and long-term follow up
All patients with coarctation (repaired or not) should be monitored with lifelong congenital 
cardiology follow-up and imaging because long-term survival is reduced compared with 
normative populations and there is potential need for reintervention [79, 80]. The European 
Society of Cardiology and the American Heart Association recommends continuous life-long 
follow up of patients with coarctation of the aorta even though they have been repaired [50]. 
As mentioned previously, even though patients with coarctation are repaired, they are at risk 
for re-coarctation later in life as well as develop other comorbidities such as hypertension and 
coronary artery disease. The unoperated mean survival rate of adults with coarctation of the 
aorta is 35 years of age, with a mortality rate of 75% by 46 years of age [49]. In general, the 
patients with CoA who are repaired at a later age are more likely to remain hypertensive. This 
is because in addition to the narrowing of the aorta, they can also develop arterial stiffness 
and vascular abnormalities asides from alternations in their renin-aldosterone angiotensin 
system [81]. Investigators have also postulated that the mechanical stress associated with 
increased pressure load may initiate rapid gene expression for collagen production, lead-
ing to re-enforcement and reorganization of the vessel musculo-elastic fascicle, and thereby 
reducing the degree of pressure-induced aortic dilatation. However, a clear disadvantage of 
this is that the resultant stiffer vessel will lead to augmented central aortic systolic pressure 
and systolic hypertension, which is the major cause of longer term morbidity and mortality in 
these patients, even despite early repair [82].
Other than being hypertensive at rest, it is also common for these patients to be hyperten-
sive with exercise. In a prospective study of 74 patients with coarctation, the systolic blood 
pressure at peak exercise was an indicator for long term hypertension [83]. Exercise stress 
testing is useful to assess the patients’ hypertensive response, evaluate their need for future 
interventions and determine prognosis in the long run [84]. Other studies have shown a link 
between exercise-induced hypertension and left ventricular hypertrophy (LVH) in patients 
with CoA. LVH has been shown to be associated with a higher incidence of adverse events 
[85]. Overall, more research is needed in this area to determine the risks and benefits of exer-
cise in patients with CoA and whether there is a need for exercise restrictions. Patients with 
CoA are also at risk for developing intracranial aneurysms (ICA). With five times the risk 
of developing ICA, guidelines recommend advanced imaging such as CT or MRI to assess 
the intracranial vessels. Studies show that screening these patients is reasonable, especially 
as they get older, since age is one of the main risk factors in the prevalence of ICA [86]. 
Hypertension will put these patients with aneurysms at risk for cerebrovascular accidents 
(CVA) and intracranial hemorrhage. In one of the studies comparing patients with congenital 
heart disease with and without CoA, the patients with CoA (especially adults, men, and the 
patients without a VSD) have a higher risk of developing hypertension, therefore increasing 
their risk for CVA [87].
Endocarditis prophylaxis is not required for patients with uncomplicated native coarcta-
tion or 6 months after successful repair of native or re-coarctation. Antibiotic prophylaxis is 
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indicated in patients with a past history of endocarditis, in those whose repair involved inser-
tion of a conduit, or for 6 months after intervention if prosthetic material or stent was used. 
The 2015 scientific statement of the AHA/ACC provides competitive athletic participation 
guidelines for patients with congenital heart disease (CHD), including coarctation [88]. As 
with any other guidelines, recommendations need to be tailored to the patient and a compre-
hensive evaluation by an experienced clinician is required. Before a decision is made regard-
ing sports participation, a detailed evaluation should be conducted, which should include 
a physical examination, electrocardiography (ECG), chest radiograph, exercise testing, and 
cardiac/aortic imaging (with transthoracic echocardiogram, MRI, and/or computed tomog-
raphy angiography [CTA]) when appropriate. The time interval for repeating this extensive 
testing is unclear and should be individualized to the specific patient.
It is known that morbidity and mortality are higher in patients with CoA given their risk of 
complications. These patients can have aortic aneurysms, chronic hypertension, re-coarctation, 
and the potential need for additional transcatheter and surgical interventions. However, for 
patients with coarctation of the aorta that survive into adulthood, studies have shown that 
their overall long-term survival rate is high. These patients should be followed up in a center 
specialized in adult congenital heart disease, where these morbidities are recognized and close 
observation is provided to prevent devastating complications.
11. Conclusion
Patients with CoA who have undergone repair require lifelong surveillance. Because this 
type of CHD is associated with many long-term complications, collaborative management by 
cardiologists with expertise in adult CHD is recommended. As patients with CHD are now 
surviving into adulthood, with 5–8% of these patients having coarctation of the aorta, it is 
important to understand the anatomy, pathophysiology, and management of these patients. 
Although echocardiography is a fundamental tool in the assessment of patients after coarcta-
tion repair, advanced imaging is often necessary for comprehensive evaluation. cMRI is the 
preferred imaging modality for repaired and unrepaired CoA. Alternatively, cardiovascular 
CT is best suited to evaluate patients with endovascular stents or those with contraindica-
tions to cMRI. It is not uncommon for this cohort to develop complications or require addi-
tional percutaneous or surgical interventions during their lifetime. This chapter emphasizes 
the importance of long-term follow up care, especially in a center specializing in the care of 
patients with congenital heart disease.
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